| Ticker Details |
IQVIA Holdings Inc.
IQVIA Holdings Inc is an information and technology-enabled healthcare service provider to the pharmaceutical services, biotechnology, and healthcare industries. The Commercial Solutions and Research and Development Solutions generate maximum revenue.
|
| IPO Date: |
May 9, 2013 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$42.84B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$2.39 | 1.31%
|
| Avg Daily Range (30 D): |
$4.59 | 2.02%
|
| Avg Daily Range (90 D): |
$3.96 | 2.05%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.05M |
| Avg Daily Volume (30 D): |
1.13M |
| Avg Daily Volume (90 D): |
1.25M |
| Trade Size |
| Avg Trade Size (Sh.): |
53 |
| Avg Trade Size (Sh.) (30 D): |
38 |
| Avg Trade Size (Sh.) (90 D): |
41 |
| Institutional Trades |
| Total Institutional Trades: |
9,557 |
| Avg Institutional Trade: |
$11.95M |
| Avg Institutional Trade (30 D): |
$18.73M |
| Avg Institutional Trade (90 D): |
$14.36M |
| Avg Institutional Trade Volume: |
.07M |
| Avg Institutional Trades (Per Day): |
4 |
| Market Closing Trades |
| Avg Closing Trade: |
$31.16M |
| Avg Closing Trade (30 D): |
$49.86M |
| Avg Closing Trade (90 D): |
$48.62M |
| Avg Closing Volume: |
170.69K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$1.54
|
$1.63
|
$3.01
|
|
Diluted EPS
|
$1.53
|
$1.61
|
$2.98
|
|
Revenue
|
$4.37B
|
$4.15B
|
$4.36B
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$258M
|
$275M
|
$514M
|
|
Operating Income / Loss
|
$506M
|
$514M
|
$627M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-38M
|
$-33M
|
$166M
|
|
PE Ratio
|
|
|
|
|
|
|
